Close Menu

substance abuse

The agency aims to fund projects that will use functional genetics and genomics to gain insights into the molecular underpinnings of substance use disorders.

The agency will genotype existing extracted DNA samples from individuals with substance abuse disorders, with data being made public after six months.

The funding will support research into epigenomic or ncRNA regulatory mechanisms in HIV/AIDS infection in the context of substance abuse and addiction.

NIDA expects to provide $3 million next year for studies using systems biology approaches to explore links between HIV/AIDS and drug use and abuse.

WSU and the Michigan Technology and Research Institute are seeking funding to form a company to shepherd to clinical trials WSU's first candidate, a triple uptake inhibitor for treating depression. They eventually hope to attract a pharma partner for further development.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.